This study will explore the effectiveness of low-dose aspirin on preventing pre-eclampsia in high-risks pregnant women by comparing the incidence of pre-eclampsia and pregnancy outcomes.
Currently,low-dose aspirin is a commonly used drug to prevent pre-eclampsia. Many guidelines recommend starting low-dose aspirin in early pregnancy in high-risks pregnant women. However, the applicable population and use method of aspirin are still controversial in clinical practice. This study will explore the effectiveness and use method of low-dose aspirin by comparing the incidence of pre-eclampsia and pregnancy outcomes.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Enrollment
600
For patients at high risk of pre-eclampsia, start taking aspirin from 12-20 weeks of pregnancy
Incidence of pre-eclampsia
Record the number of pre-eclampsia in each group and compare whether there are statistical differences in the incidence of each group
Time frame: 1 year
Preterm birth
Record the number of preterm in each group and compare whether there are statistical differences in the incidence of each group
Time frame: 1 year
Fetal growth restriction
Record the number of FGR in each group and compare whether there are statistical differences in the incidence of each group
Time frame: 1 year
Placental abruption 4/5000 Placental abruption
Record the number of placental abruption in each group and compare whether there are statistical differences in the incidence of each group
Time frame: 1 year
Postpartum hemorrhage
Record the number of postpartum hemorrhage in each group and compare whether there are statistical differences in the incidence of each group
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.